Moreover, prostate cancer exosomes can activate TGF-β1-dependent fibroblast differentiation to the myofibroblast phenotype and promote tumor growth and angiogenesis, but the direct use of soluble TGF-β1 cannot achieve these cancer-promoting effects. Here, TGFB1 is linked to prostate cancer.